Zaltrap 200 mg/8 ml, concentré pour solution pour perfusion

7680626760026 CH-62676 concentré pour solution pour perfusion
Zaltrap 200 mg/8 ml, concentré pour solution pour perfusion
Zaltrap 200 mg/8 ml, concentré pour solution pour perfusion
Zaltrap 200 mg/8 ml, concentré pour solution pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
concentré pour solution pour perfusion
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/10/2024
Summary of Product Characteristics
Français
18/10/2024
Summary of Product Characteristics
Italien
18/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 862.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2013

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
62676
Drug name
Zaltrap, concentré pour solution pour perfusion
Galenic form
KOPA
ATC Code
L01XX44
Authorization status
Z
Dispensing category
A
First authorization
20/03/2013
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
ZALTRAP conc perf 200 mg/8ml flac 8 ml
Description (DE)
ZALTRAP Inf Konz 200 mg/8ml Durchstf 8 ml
Market launch
20/03/2013
Narcotic (BTM)
No

Other package sizes (1)

ZALTRAP conc perf 100 mg/4ml flac 4 ml
1 DUR
GTIN: 7680626760019
View